BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15965313)

  • 1. Combination treatment of clozapine and topiramate in resistant rapid-cycling bipolar disorder.
    Chen CK; Shiah IS; Yeh CB; Mao WC; Chang CC
    Clin Neuropharmacol; 2005; 28(3):136-8. PubMed ID: 15965313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design.
    Grunze HC; Normann C; Langosch J; Schaefer M; Amann B; Sterr A; Schloesser S; Kleindienst N; Walden J
    J Clin Psychiatry; 2001 Jun; 62(6):464-8. PubMed ID: 11465524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute mania with topiramate in hospitalized patients.
    Bozikas VP; Petrikis P; Kourtis A; Youlis P; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1203-6. PubMed ID: 12452547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
    Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate leukopenia on clozapine.
    Behar D; Schaller JL
    Eur Child Adolesc Psychiatry; 2004 Feb; 13(1):51-2. PubMed ID: 14991432
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjunctive topiramate in bipolar II disorder.
    Vieta E; Sánchez-Moreno J; Goikolea JM; Torrent C; Benabarre A; Colom F; Martínez-Arán A; Reinares M; Comes M; Corbella B
    World J Biol Psychiatry; 2003 Oct; 4(4):172-6. PubMed ID: 14608588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive topiramate in ultradian cycling bipolar disorder: case report with 3-year follow-up.
    Karama S; Lal S
    Eur Psychiatry; 2006 Jun; 21(4):280-1. PubMed ID: 16360310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine and lithium as maintenance therapy in a young treatment-resistant bipolar patient.
    Amerio A; Odone A
    Asian J Psychiatr; 2018 Aug; 36():94-95. PubMed ID: 30048862
    [No Abstract]   [Full Text] [Related]  

  • 10. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial.
    Tramontina S; Zeni CP; Pheula G; Rohde LA
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):129-34. PubMed ID: 17343561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN; Gershon S; Levine J
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term effectiveness of clozapine and lamotrigine in a patient with treatment-resistant rapid-cycling bipolar disorder.
    Bastiampillai TJ; Reid CE; Dhillon R
    J Psychopharmacol; 2010 Dec; 24(12):1834-6. PubMed ID: 20142304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
    Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
    Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
    Vieta E; Sánchez-Moreno J; Goikolea JM; Colom F; Martínez-Arán A; Benabarre A; Corbella B; Torrent C; Comes M; Reinares M; Brugue E
    J Clin Psychopharmacol; 2004 Aug; 24(4):374-8. PubMed ID: 15232327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.
    Hahn MK; Remington G; Bois D; Cohn T
    J Clin Psychopharmacol; 2010 Dec; 30(6):706-10. PubMed ID: 21105286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label adjunctive topiramate in the treatment of bipolar disorders.
    McElroy SL; Suppes T; Keck PE; Frye MA; Denicoff KD; Altshuler LL; Brown ES; Nolen WA; Kupka RW; Rochussen J; Leverich GS; Post RM
    Biol Psychiatry; 2000 Jun; 47(12):1025-33. PubMed ID: 10862801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
    Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate as a mood stabilizer.
    Letmaier M; Schreinzer D; Wolf R; Kasper S
    Int Clin Psychopharmacol; 2001 Sep; 16(5):295-8. PubMed ID: 11552774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid cycling--finally stable but obese--target acquired?].
    Reininghaus B; Bengesser SA; Reininghaus E; Lackner N; Kapfhammer HP; Birner A
    Fortschr Neurol Psychiatr; 2014 Dec; 82(12):701-5. PubMed ID: 25489759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.